Alyeska Investment Group
SRPT icon

Alyeska Investment Group’s Sarepta Therapeutics SRPT Stock Holding History

Alyeska Investment Group’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,997
Closed -$3.04M – 650
2024
Q4 		$3.04M Sell
24,997
-210,243
-89% -$25.8M 0.01% 442
2024
Q3 		$29.4M Buy
235,240
+175,240
+292% +$24.2M 0.15% 197
2024
Q2 		$9.48M Buy
+60,000
New +$7.71M 0.05% 277
2023
Q3 		– Sell
-27,869
Closed -$3.19M – 618
2023
Q2 		$3.19M Buy
+27,869
New +$3.59M 0.02% 372
2020
Q2 		– Sell
-4,708
Closed -$461K – 566
2020
Q1 		$461K Sell
4,708
-283,659
-98% -$32.4M 0.01% 331
2019
Q4 		$37.2M Sell
288,367
-186,887
-39% -$18.9M 0.49% 74
2019
Q3 		$35.8M Buy
475,254
+93,319
+24% +$11M 0.52% 65
2019
Q2 		$58M Sell
381,935
-20,357
-5% -$2.47M 0.75% 37
2019
Q1 		$47.9M Buy
402,292
+130,002
+48% +$16.7M 0.63% 48
2018
Q4 		$29.7M Sell
272,290
-102,092
-27% -$12.8M 0.43% 87
2018
Q3 		$60.5M Sell
374,382
-78,842
-17% -$10.8M 0.66% 49
2018
Q2 		$59.9M Buy
453,224
+272,943
+151% +$25.7M 0.54% 67
2018
Q1 		$13.4M Sell
180,281
-871,192
-83% -$58.1M 0.11% 201
2017
Q4 		$58.5M Buy
1,051,473
+478,033
+83% +$25.3M 0.47% 78
2017
Q3 		$26M Buy
+573,440
New +$22.9M 0.19% 156

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Alyeska Investment Group's SRPT Position: Q1 2025 in Review

Alyeska Investment Group sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 24,997 shares — an estimated $3.04M sold.

Alyeska Investment Group first reported a position in SRPT in Q3 2017 and held it in 15 quarters. The position peaked at $60.5M in Q3 2018. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Alyeska Investment Group reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 24,997 Sarepta Therapeutics shares in Q1 2025, an estimated $3.04M.
  • Alyeska Investment Group first reported a position in Sarepta Therapeutics in Q3 2017 and held it in 15 quarters.
  • Alyeska Investment Group's Sarepta Therapeutics position peaked at $60.5M in Q3 2018.
  • 431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.